The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
Condition: Pancreas Cancer · Adenocarcinoma of the Pancreas · Pancreatic Cancer · Sponsor: HistoSonics, Inc.
About this study
The purpose of this trial is to evaluate the safety of the HistoSonics Edison System for the destruction of pancreatic adenocarcinomas using histotripsy.
This description comes directly from the study's public registry record.
Talk to the study team
Zoe Secord · 612-351-0361 · zoe.secord@histosonics.com
Always discuss trial participation with your own doctor first.
Locations (1)
| Hospital de la Santa Creu i Sant Pau | Barcelona, Spain | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06282809